AGER and Alzheimer disease: The receptor for advanced glycation end products (RAGE) is a multi-ligand receptor and a member of the immunoglobulin family that has been shown to be elevated in several neurological conditions, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, myasthenia gravis, and cerebrovascular disease [26].